About Us
Ixtlan Bioscience
Ixtlan Bioscience is an Israeli based biotech company focused on developing psilocybin-based micro-dosing treatment complemented by personalized cognitive AI based exercises, aimed to open and utilize the window of plasticity for treatment of Alzheimer’s Disease and brain pathologies.
With our professional team’s expertise in neuroscience and neuropsychiatry as well as background in academic research in Alzheimer and dementia, we understand failures of the healthcare system to provide at-home neurorecovery solutions, which would provide accessibility to those unable to easily commute to receive in-person therapy.
In light of this crisis, our initial focus is developing our novel and proprietary, patent pending, Ixtlan AD Kit, for the at-home treatment of patients suffering from Alzheimer’s and dementia diseases.
We at Ixtlan envision a future where everyone has the opportunity to benefit from safe and accessible psilocybin medicine and are determined to increase the access to transformative power of these compounds.